AltMountain

TPG Life Sciences Innovations Access LLC

New York, NY · CIK 1945873 · Sponsor: TPG Life Sciences Innovations
Status: no Form D since Sep 2023. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

TPG Life Sciences Innovations Access LLC is a private investment fund based in New York, New York. According to its most recent Form D, filed Sep 8, 2023, it has sold $134,555,000 of interests to 176 investors since its first sale in Sep 2022. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Richard Ruffer; Jody Flaws; Ashish Dodia.

Total raised
$134,555,000Cumulative sales reported on Form D
Investors
176
First sale
Sep 5, 2022
Minimum investment
None set
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Richard Ruffer; Jody Flaws; Ashish Dodia
Latest Form D
Sep 8, 2023

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌‌​⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Sep 8, 2023Form D/A (amendment)$134,555,000176SEC.gov ↗
Sep 13, 2022Form D$9,350,00028SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Sep 13, 2022. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Vehicles of this fund (2)

Legal name on Form DSEC CIKLocation reportedTotal raisedInvestorsMinimumLatest Form D
TPG Life Sciences Innovations Access LLC (main vehicle on this page)1945873New York, New York$134,555,000176$0Sep 8, 2023
TPG Life Sciences Innovations Access Offshore LP1945874New York, New York$9,000,0008$0Sep 8, 2023

Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 2 filings carry the same name apart from such vehicle words or a series letter and report the same location or the same adviser, so AltMountain shows them on one page; the details above are those of TPG Life Sciences Innovations Access LLC, the vehicle reporting the most raised. Each row is that vehicle's own filing, exactly as filed. The amounts should not be added together, because a feeder's money can also be counted in its master fund. Grouped by AltMountain from the filings; not confirmed by the fund. The CIK links open each vehicle's filings on SEC.gov. Source: SEC Form D filings.

Raise history: TPG Life Sciences Innovations Access Offshore LP

FiledFilingTotal raisedInvestorsSource
Sep 8, 2023Form D/A (amendment)$9,000,0008SEC.gov ↗
Sep 13, 2022Form D$250,0001SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Sep 13, 2022. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about TPG Life Sciences Innovations Access LLC

What is the minimum investment for TPG Life Sciences Innovations Access LLC?

TPG Life Sciences Innovations Access LLC's latest Form D, filed Sep 8, 2023, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in TPG Life Sciences Innovations Access LLC?

TPG Life Sciences Innovations Access LLC is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has TPG Life Sciences Innovations Access LLC raised?

TPG Life Sciences Innovations Access LLC reports $134,555,000 sold from 176 investors on its Form D filed Sep 8, 2023. This is cumulative sales since the offering began, not current assets or performance.

Where is TPG Life Sciences Innovations Access LLC based?

TPG Life Sciences Innovations Access LLC is based in New York, New York.

When did TPG Life Sciences Innovations Access LLC launch?

TPG Life Sciences Innovations Access LLC reports its first sale in Sep 2022.

Size compared with every private investment fund

Raised more than 74% of the 2,846 private investment funds based in New York, and more than 75% of all 10,324 that report sales.

Other programs from TPG Life Sciences Innovations

All 2 funds from this sponsor

More private investment funds in New York

Similar-size private investment funds in New York

All private investment funds in New York